Search
Karyopharm Therapeutics Inc
KPTIAdd to Watchlist
9.600USD
+0.050+0.52%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
175.79MMarket Cap
LossP/E TTM
Karyopharm Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
146.07M
0.57%
EPS(YoY)
-17.93
-90.58%
Analyst Rating
BUY
2026-07-04
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Karyopharm Therapeutics Inc?
According to Karyopharm Therapeutics Inc's FY2025 earnings report, its total revenue reached 146.07M, with a year-on-year change of 0.57.
What are the current assets of Karyopharm Therapeutics Inc?
According to Karyopharm Therapeutics Inc's FY2025 earnings report, its current assets were 103.15M, with a year-on-year change of -34.09.
What are the total assets of Karyopharm Therapeutics Inc?
According to Karyopharm Therapeutics Inc's FY2025 earnings report, its total assets of Karyopharm Therapeutics Inc were 108.42M, with a year-on-year change of -34.06.
What are the total liabilities of Karyopharm Therapeutics Inc?
According to Karyopharm Therapeutics Inc's FY2025 earnings report, its total liabilities of Karyopharm Therapeutics Inc were 401.34M, with a year-on-year change of 14.53.
What is the total equity of Karyopharm Therapeutics Inc?
According to Karyopharm Therapeutics Inc's FY2025 earnings report, its total equity of Karyopharm Therapeutics Inc was -292.93M, with a year-on-year change of -57.47.
What is the net investment of Karyopharm Therapeutics Inc?
According to Karyopharm Therapeutics Inc's FY2025 earnings report, its net investment of Karyopharm Therapeutics Inc was 43.38M, with a year-on-year change of -54.57.
What is the net financing of Karyopharm Therapeutics Inc?
According to Karyopharm Therapeutics Inc's FY2025 earnings report, its net financing of Karyopharm Therapeutics Inc was 30.05M, with a year-on-year change of -27.85.
What is the Earnings Per Share (EPS) of Karyopharm Therapeutics Inc?
According to Karyopharm Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -17.93, with a year-on-year change of -90.58.
What is the net margin of Karyopharm Therapeutics Inc?
According to Karyopharm Therapeutics Inc's FY2025 earnings report, its net profit margin was -134.21, with a year-on-year change of -155.06.
What is the gross margin of Karyopharm Therapeutics Inc?
According to Karyopharm Therapeutics Inc's FY2025 earnings report, its gross margin was 95.93, with a year-on-year change of 0.07.
What is the debt-to-asset ratio of Karyopharm Therapeutics Inc?
According to Karyopharm Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 276.00, with a year-on-year change of 73.95.
What is the Return on Assets (ROA) of Karyopharm Therapeutics Inc?
According to Karyopharm Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -143.71, with a year-on-year change of -280.65.
What is the operating profit of Karyopharm Therapeutics Inc?
According to Karyopharm Therapeutics Inc's FY2025 earnings report, its operating profit was -90.71M, with a year-on-year change of 24.06.